Clinical features and complications [1] These are listed in order of the most common at diagnosis:
The defining symptom is a chronic peripheral neuropathy, with motor features predominating:
It starts in the feet with paraesthesia.
There is symmetrical and proximal spread. Progression is usually gradual but can be rapid. Respiratory muscles may be affected. Some patients also have pain.
Osteosclerotic lesions: Occur in 95% of patients. May be solitary or multiple; there may be mixed sclerotic and lytic lesions.
Skin changes: Hyperpigmentation and hypertrichosis are common; coarse black hair may occur on the extremities. Other skin changes are: thickening, haemangiomata, plethora, clubbing, white nails.
Endocrinopathy: [5] Most commonly, hypogonadism. Diabetes and hypothyroidism are also common. Adrenal insufficiency and hypocalcaemia can occur. There may be multiple endocrine axes affected. Investigations [3] Blood tests Serum proteins investigations: [1] By definition, all patients have a monoclonal plasma-proliferative disorder. The monoclonal protein is typically small; it may be missed on electrophoresis unless immunofixation is done on both serum and 24-hour urine.
Biopsy
Nerve biopsies -usually reveal evidence of axonal degeneration and demyelination.
Differential diagnosis [3] Chronic inflammatory demyelinating polyneuropathy. Monoclonal gammopathy of undetermined significance with associated peripheral neuropathy. Multiple myeloma -may have polyneuropathy and, rarely, can present with diffuse osteosclerotic bone lesions. [6] Solitary plasmacytoma of bone -may have a small amount of monoclonal protein in serum or urine. Waldenström's macroglobulinaemia.
Associated diseases [2] The interconnections between POEMS syndrome, osteosclerotic myeloma and Castleman's disease are still under investigation. Possible associations include pulmonary hypertension, restrictive lung disease, thrombotic diatheses, arthralgias, cardiomyopathy and low vitamin B12.
Management [1, 3] There is currently insufficient evidence regarding the treatment options for POEMS syndrome on which to base practice. [7] Supportive care as required for neurological and respiratory problems -eg, physiotherapy, occupational therapy, respiratory support or multidisciplinary care. Radiotherapy -if the osteosclerotic lesions are single or restricted to a limited area. [8] If osteosclerotic lesions are widespread -chemotherapy or autologous stem cell transplantation. [9] Possible treatments include: Melphalan and prednisolone. Cyclophosphamide ± prednisolone. High-dose chemotherapy with stem cell transplantation. Lenalidomide -has been used with some success. [10] Thalidomide and bortezomib -may be effective but risk exacerbating peripheral neuropathy. The benefit of anti-VEGF antibodies is conflicting. [8] 
Prognosis
The median survival of patients with POEMS syndrome is about 14 years. [2] Prompt recognition and institution of supportive care measures and therapy directed against the plasma cell result in the best outcomes. [10] Further reading & references
